- Home
- FFIN vs APGE Comparison
FFIN vs APGE Comparison
Compare FFIN & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FFIN | APGE |
|---|---|---|
| Founded | 1890 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.7B |
| IPO Year | 1994 | 2023 |
Fundamental Metrics
Financial Performance| Metric | FFIN | APGE |
|---|---|---|
| Price | $32.43 | $90.78 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $36.50 | ★ $109.67 |
| AVG Volume (30 Days) | 578.3K | ★ 881.1K |
| Earning Date | 04-16-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.36% | N/A |
| EPS Growth | ★ 13.46 | N/A |
| EPS | ★ 1.77 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.16 | N/A |
| Revenue Next Year | $6.61 | N/A |
| P/E Ratio | $18.19 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.12 | $34.34 |
| 52 Week High | $38.74 | $95.32 |
Technical Indicators
Market Signals| Indicator | FFIN | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 63.72 | 68.55 |
| Support Level | $31.08 | $73.06 |
| Resistance Level | $34.79 | N/A |
| Average True Range (ATR) | 0.80 | 3.27 |
| MACD | 0.25 | 0.27 |
| Stochastic Oscillator | 82.04 | 69.28 |
Price Performance
Historical ComparisonAbout FFIN First Financial Bankshares Inc.
First Financial Bankshares Inc is a financial and bank holding company. The company operates one line of business (community banking) located in a single geographic area (Texas). The company conducts a full-service commercial banking business through its subsidiaries. The loan portfolio segments of the company include Commercial and Industrial, Municipal, Agricultural, Construction and Development, Farm, Non-Owner Occupied and Owner Occupied Commercial Real Estate, Residential, Consumer Auto and Consumer Non-Auto.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.